Baillie Gifford & CO Unity Biotechnology, Inc. Transaction History

Baillie Gifford & CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 19, 2021	SELL	$2.91 - $4.5 $4.99 Million - $7.72 Million	-1,715,000 Reduced 74.43%	589,111 $1.77 Million
Q2 2021 Aug 02, 2021	SELL	$4.15 - $6.3 $6.22 Million - $9.44 Million	-1,498,903 Reduced 39.41%	2,304,111 $10.7 Million
Q2 2018 Jul 17, 2018	BUY	$12.76 - $16.94 $48.5 Million - $64.4 Million	3,803,014 New	3,803,014 $57.3 Million

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $14M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

Stay updated on Baillie Gifford & CO with notifications on news.